BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 33008449)

  • 21. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
    Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
    J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer.
    Cao Y; Wang J; Tian H; Fu GH
    J Exp Clin Cancer Res; 2020 Jun; 39(1):119. PubMed ID: 32576206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular RNA circCCDC9 acts as a miR-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression.
    Luo Z; Rong Z; Zhang J; Zhu Z; Yu Z; Li T; Fu Z; Qiu Z; Huang C
    Mol Cancer; 2020 May; 19(1):86. PubMed ID: 32386516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of TPT1-AS1 inhibits cell proliferation, cell cycle G1/S transition, and epithelial-mesenchymal transition in gastric cancer.
    Tang J; Huang F; Wang H; Cheng F; Pi Y; Zhao J; Li Z
    Bosn J Basic Med Sci; 2021 Feb; 21(1):39-46. PubMed ID: 32156253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
    Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
    J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis.
    Xiang Z; Zhou ZJ; Xia GK; Zhang XH; Wei ZW; Zhu JT; Yu J; Chen W; He Y; Schwarz RE; Brekken RA; Awasthi N; Zhang CH
    Oncogene; 2017 Sep; 36(36):5122-5133. PubMed ID: 28481874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis.
    Ding K; Tan S; Huang X; Wang X; Li X; Fan R; Zhu Y; Lobie PE; Wang W; Wu Z
    J Biol Chem; 2018 Mar; 293(11):3949-3964. PubMed ID: 29367342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation.
    Xie M; Yu T; Jing X; Ma L; Fan Y; Yang F; Ma P; Jiang H; Wu X; Shu Y; Xu T
    Mol Cancer; 2020 Jun; 19(1):112. PubMed ID: 32600329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
    Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
    Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
    Zhang Y; Yin W; Cao W; Chen P; Bian L; Ni Q
    Oncol Rep; 2019 Apr; 41(4):2471-2481. PubMed ID: 30816466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells.
    Feng X; Zhu M; Liao B; Tian T; Li M; Wang Z; Chen G
    Oncol Res Treat; 2020; 43(3):103-111. PubMed ID: 31958799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SATB1 3'-UTR and lncRNA-UCA1 competitively bind to miR-495-3p and together regulate the proliferation and invasion of gastric cancer.
    Sun L; Liu L; Yang J; Li H; Zhang C
    J Cell Biochem; 2019 Apr; 120(4):6671-6682. PubMed ID: 30368875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic silencing of microRNA-204 by Helicobacter pylori augments the NF-κB signaling pathway in gastric cancer development and progression.
    Chen P; Guo H; Wu X; Li J; Duan X; Ba Q; Wang H
    Carcinogenesis; 2020 Jun; 41(4):430-441. PubMed ID: 31873718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer.
    Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BDH2 triggers ROS-induced cell death and autophagy by promoting Nrf2 ubiquitination in gastric cancer.
    Liu JZ; Hu YL; Feng Y; Jiang Y; Guo YB; Liu YF; Chen X; Yang JL; Chen YY; Mao QS; Xue WJ
    J Exp Clin Cancer Res; 2020 Jun; 39(1):123. PubMed ID: 32605589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. M-phase phosphoprotein 8 promotes gastric cancer growth and metastasis via p53/Bcl-2 and EMT-related signaling pathways.
    Wang Y; Xiao H; Wang C; Wu H; He H; Yao C; Cui J; Li W
    J Cell Biochem; 2020 Mar; 121(3):2330-2342. PubMed ID: 31692032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. XB130 promotes proliferation and invasion of gastric cancer cells.
    Shi M; Zheng D; Sun L; Wang L; Lin L; Wu Y; Zhou M; Liao W; Liao Y; Zuo Q; Liao W
    J Transl Med; 2014 Jan; 12():1. PubMed ID: 24387290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysine-222 succinylation reduces lysosomal degradation of lactate dehydrogenase a and is increased in gastric cancer.
    Li X; Zhang C; Zhao T; Su Z; Li M; Hu J; Wen J; Shen J; Wang C; Pan J; Mu X; Ling T; Li Y; Wen H; Zhang X; You Q
    J Exp Clin Cancer Res; 2020 Aug; 39(1):172. PubMed ID: 32859246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.